1. Home
  2. BCAB vs WKSP Comparison

BCAB vs WKSP Comparison

Compare BCAB & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • WKSP
  • Stock Information
  • Founded
  • BCAB 2007
  • WKSP 2003
  • Country
  • BCAB United States
  • WKSP United States
  • Employees
  • BCAB N/A
  • WKSP N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • WKSP Auto Parts:O.E.M.
  • Sector
  • BCAB Health Care
  • WKSP Consumer Discretionary
  • Exchange
  • BCAB Nasdaq
  • WKSP Nasdaq
  • Market Cap
  • BCAB 27.0M
  • WKSP 22.0M
  • IPO Year
  • BCAB 2020
  • WKSP N/A
  • Fundamental
  • Price
  • BCAB $0.32
  • WKSP $2.68
  • Analyst Decision
  • BCAB Buy
  • WKSP Strong Buy
  • Analyst Count
  • BCAB 2
  • WKSP 2
  • Target Price
  • BCAB $1.00
  • WKSP $15.75
  • AVG Volume (30 Days)
  • BCAB 534.1K
  • WKSP 212.5K
  • Earning Date
  • BCAB 05-13-2025
  • WKSP 05-15-2025
  • Dividend Yield
  • BCAB N/A
  • WKSP N/A
  • EPS Growth
  • BCAB N/A
  • WKSP N/A
  • EPS
  • BCAB N/A
  • WKSP N/A
  • Revenue
  • BCAB $11,000,000.00
  • WKSP $8,484,379.00
  • Revenue This Year
  • BCAB N/A
  • WKSP $227.66
  • Revenue Next Year
  • BCAB N/A
  • WKSP $52.23
  • P/E Ratio
  • BCAB N/A
  • WKSP N/A
  • Revenue Growth
  • BCAB N/A
  • WKSP 454.67
  • 52 Week Low
  • BCAB $0.24
  • WKSP $2.59
  • 52 Week High
  • BCAB $3.53
  • WKSP $12.00
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 47.19
  • WKSP 28.40
  • Support Level
  • BCAB $0.26
  • WKSP $2.97
  • Resistance Level
  • BCAB $0.34
  • WKSP $3.44
  • Average True Range (ATR)
  • BCAB 0.04
  • WKSP 0.33
  • MACD
  • BCAB 0.00
  • WKSP 0.12
  • Stochastic Oscillator
  • BCAB 58.00
  • WKSP 18.56

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About WKSP Worksport Ltd.

Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers.

Share on Social Networks: